ClinicalTrials.gov
public full text
Public Domain
The Phase I Study of Recombinant Human Nerve Growth Factor Injection
A randomized, double-blind, placebo-controlled, single/multiple dose study of recombinant human nerve growth factor injection in healthy Chinese volunteers on safety, tolerability and pharmacokinetics
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Epidermal growth factor receptor modulation for neural repair: Implications for neurodegenerative disease therapy.#452889
- PRGF Effectiveness for Myofascial Pain Treatment in Masticatory Muscles#1320976
- A Randomized Study to Evaluate the Efficacy of a Reduced Starting Dose of Lazertinib (Leclaza) and Preemtive Magnesium Supplementation to Prevent Lazertinib(Leclaza)-Induced Peripheral Neuropathy#802952
- Local Anesthetic Concentration and Nerve Block Duration#901096
- Effects of Benfotiamine on Intraepidermal Nerve Fiber Density (IENFD)#833929
Record · ID 1296042
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive